Published in Proc Natl Acad Sci U S A on December 01, 1980
Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev (1984) 19.14
Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci U S A (1995) 2.14
Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc Natl Acad Sci U S A (1989) 1.61
Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One (2009) 1.57
Some features of the mutability of bacteria during nonlethal selection. Genetics (2000) 1.29
Chemical carcinogenesis: a biologic perspective. Am J Pathol (1982) 1.26
Ionizing radiation-induced mutagenesis. Br J Cancer (1988) 1.15
Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucleic Acids Res (1999) 1.14
Some recollections and reflections on mutation rates. Genetics (1998) 1.06
The oncogenic transforming potential of the passage of single alpha particles through mammalian cell nuclei. Proc Natl Acad Sci U S A (1999) 1.05
The mysterious steps in carcinogenesis. Br J Cancer (2009) 1.04
Transgenerational accumulation of radiation damage in small mammals chronically exposed to Chernobyl fallout. Radiat Environ Biophys (2006) 0.97
Inhibition of radiation-induced neoplastic transformation by beta-lapachone. Proc Natl Acad Sci U S A (1989) 0.96
Chemical carcinogens transform BHK cells by inducing a recessive mutation. Mol Cell Biol (1982) 0.94
Transformation of BALB/c-3T3 cells: I. Investigation of experimental parameters that influence detection of spontaneous transformation. Environ Health Perspect (1993) 0.93
Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks. Br J Cancer (1981) 0.93
Heritable, population-wide damage to cells as the driving force of neoplastic transformation. Proc Natl Acad Sci U S A (1995) 0.92
Oncogenic transformation of murine C3H 10T1/2 cells resulting from DNA double-strand breaks induced by a restriction endonuclease. Br J Cancer (1989) 0.92
Experimental control of neoplastic progression in cell populations: Foulds' rules revisited. Proc Natl Acad Sci U S A (1994) 0.92
The effect of environmental chemicals on the tumor microenvironment. Carcinogenesis (2015) 0.91
Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Proc Natl Acad Sci U S A (1985) 0.91
A critical test of the role of population density in producing transformation. Proc Natl Acad Sci U S A (1994) 0.86
Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion. Proc Natl Acad Sci U S A (1995) 0.86
Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density. Proc Natl Acad Sci U S A (1995) 0.86
Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors. Proc Natl Acad Sci U S A (1995) 0.86
Incipient and overt stages of neoplastic transformation. Proc Natl Acad Sci U S A (1994) 0.85
An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases. Proc Natl Acad Sci U S A (1985) 0.85
Cellular epigenetics: topochronology of progressive "spontaneous" transformation of cells under growth constraint. Proc Natl Acad Sci U S A (1994) 0.82
Diagnostic ultrasound time-lapse and transmission electron microscopic studies of cells insonated in vitro. Br J Cancer Suppl (1982) 0.81
Is there a critical target gene for the first step in carcinogenesis? Environ Health Perspect (1991) 0.81
Increased radiation-induced transformation in C3H/10T1/2 cells after transfer of an exogenous c-myc gene. Proc Natl Acad Sci U S A (1987) 0.81
Stromal mediation of radiation carcinogenesis. J Mammary Gland Biol Neoplasia (2010) 0.80
Malignant transformation induced by incorporated radionuclides in BALB/3T3 mouse embryo fibroblasts. Proc Natl Acad Sci U S A (1982) 0.80
Cooperative effects of photodynamic treatment of cells in microcolonies. Proc Natl Acad Sci U S A (1997) 0.79
Selective nature of phorbol 12-myristate 13-acetate-induced neoplastic transformation in NIH 3T3 cells. Proc Natl Acad Sci U S A (1994) 0.79
Differential cell cycle phase specificity for neoplastic transformation and mutation to ouabain resistance induced by N-methyl-N'-nitro-N-nitrosoguanidine in synchronized C3H10T 1/2 C18 cells. Proc Natl Acad Sci U S A (1982) 0.77
Molecular biology of deregulated gene expression in transformed C3H/10T1/2 mouse embryo cell lines induced by specific insoluble carcinogenic nickel compounds. Environ Health Perspect (2002) 0.77
Linking the history of radiation biology to the hallmarks of cancer. Radiat Res (2014) 0.76
Development of insusceptibility to serum factor during the radiation transformation process. Br J Cancer (1983) 0.75
Ubiquitous, heritable damage in cell populations that survive treatment with methotrexate. Proc Natl Acad Sci U S A (1997) 0.75
Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics (1943) 165.64
ENZYME INDUCTION AS AN ALL-OR-NONE PHENOMENON. Proc Natl Acad Sci U S A (1957) 14.34
Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res (1973) 7.59
Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res (1973) 4.54
X-radiation-induced transformation in a C3H mouse embryo-derived cell line. Cancer Res (1976) 1.72
In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate. Proc Natl Acad Sci U S A (1970) 1.53
Transformation of mouse C3H/10T1/2 cells by single and fractionated doses of X-rays and fission-spectrum neutrons. Cancer Res (1979) 1.29
Cell density dependence of focus formation in the C3H/10T1/2 transformation assay. Cancer Res (1977) 1.20
Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Res (1978) 1.12
Dynamics of neoplastic development in carcinogen-exposed tracheal mucosa. Cancer Res (1979) 1.11
Effects of serum concentration on the expression of carcinogen-induced transformation in the C3H/10T1/2 CL8 cell line. Cancer Res (1977) 1.11
Effect of time and duration of exposure to 12-O-tetradecanoylphorbol-13-acetate on x-ray transformation of C3H 10T 1/2 cells. Cancer Res (1980) 1.04
Models of carcinogenesis as an escape from mitotic inhibitors. Science (1976) 1.01
Morphological transformation of C3H/10T1/2 cells subcultured at low cell densities. Life Sci (1978) 0.94
Contributions of microbiology to eucaryotic cell biology: new directions for microbiology. Microbiol Rev (1979) 0.86
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24
floricaula: a homeotic gene required for flower development in antirrhinum majus. Cell (1990) 6.52
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol (1967) 5.87
Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol (2001) 5.05
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
FCA, a gene controlling flowering time in Arabidopsis, encodes a protein containing RNA-binding domains. Cell (1997) 4.79
Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res (1992) 4.72
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Multiple independent defective suppressor-mutator transposon insertions in Arabidopsis: a tool for functional genomics. Plant Cell (1999) 4.57
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem (1985) 3.51
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med (1989) 3.03
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat Res (1998) 2.92
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett (1992) 2.88
Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci U S A (1996) 2.77
Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A (2001) 2.74
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: evidence for a bystander effect. Radiat Res (1999) 2.70
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med (1992) 2.59
Conservation of microstructure between a sequenced region of the genome of rice and multiple segments of the genome of Arabidopsis thaliana. Genome Res (2001) 2.56
Molecular characterization and regulation of the rhizosphere-expressed genes rhiABCR that can influence nodulation by Rhizobium leguminosarum biovar viciae. J Bacteriol (1992) 2.55
Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil (2013) 2.54
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Repair of potentially lethal radiation damage in vitro and in vivo. Radiology (1973) 2.43
Locus control region function and heterochromatin-induced position effect variegation. Science (1996) 2.42
Airborne spread of measles in a suburban elementary school. Am J Epidemiol (1978) 2.37
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet (1998) 2.34
Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell (1998) 2.18
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther (2013) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen (2000) 2.15
Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem (2000) 2.12
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
Fatality rates and regulatory policies in bituminous coal mining, United States, 1959-1981. Am J Public Health (1983) 2.11
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Molecular evolution of the human adult alpha-globin-like gene region: insertion and deletion of Alu family repeats and non-Alu DNA sequences. Proc Natl Acad Sci U S A (1983) 2.07
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Opinion statement on the minimal acceptable standards of healthcare in cerebral palsy. Disabil Rehabil (2001) 2.05
The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics (1991) 2.03
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett (2000) 2.03
Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. Curr Top Radiat Res Q (1972) 2.02
Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol (1971) 2.01
Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study. Aliment Pharmacol Ther (2014) 1.99
VY bipedicle flap for resurfacing the nasal supratip region. Plast Reconstr Surg (1989) 1.98
Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett (1996) 1.97
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis (1997) 1.92
Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology (1996) 1.91
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun (2000) 1.90
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86
The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem (1992) 1.85
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol (1996) 1.82
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis (1990) 1.80
Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect (2004) 1.79
TAC use and absorption of cocaine in a pediatric emergency department. Ann Emerg Med (1990) 1.75
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Fatal hepatoxicity secondary to nimesulide. Eur J Clin Pharmacol (2001) 1.72
X-radiation-induced transformation in a C3H mouse embryo-derived cell line. Cancer Res (1976) 1.72
Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest (2001) 1.71
Lung cancer induced in hamsters by low doses of alpha radiation from polonium-210. Science (1975) 1.71
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem (1995) 1.70
Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem (1996) 1.66
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J (1980) 1.64
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62
Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer (1999) 1.61
Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet. J Neurol Neurosurg Psychiatry (2009) 1.60
The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am J Hum Genet (2000) 1.60
The National Cancer Data Base report on prostate cancer. Cancer (1994) 1.60
Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res (1992) 1.60